Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations
Objectives Corruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors globally. Throughout the COVID-19 pandemic, weakened...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/12/e064137.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850188148688027648 |
|---|---|
| author | Jillian Kohler Ariel Gorodensky Andrea Bowra Gul Saeed |
| author_facet | Jillian Kohler Ariel Gorodensky Andrea Bowra Gul Saeed |
| author_sort | Jillian Kohler |
| collection | DOAJ |
| description | Objectives Corruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors globally. Throughout the COVID-19 pandemic, weakened health systems and overlooked regulatory processes have increased corruption risks. The objective of this study is thus to explore the strengths and weaknesses of these organisations’ anti-corruption mechanisms and their trajectories since the pandemic began.Design, setting and participants 25 semistructured key informant interviews with a total of 27 participants were conducted via Zoom between April and July 2021 with informants from WHO, World Bank, Global Fund and UNDP, other non-governmental organisations involved in anti-corruption and academic institutions. Key informant selection was guided by purposive and snowball sampling. Detailed interview notes were qualitatively coded by three researchers. Data analysis followed an inductive-deductive hybrid thematic analysis framework.Results The findings demonstrate that WHO, World Bank, Global Fund and UNDP have shifted from criminalisation/punitive approaches to anti-corruption to preventative ones and that anti-corruption initiatives are strong when they are well funded, explicitly address corruption and are complemented by strong monitoring and evaluation mechanisms. Weaknesses in the organisations’ approaches to anti-corruption include one-size-fits-all approaches, lack of political will to address corruption and zero-tolerance policies for corruption. The COVID-19 pandemic has highlighted the necessity of improving anti-corruption by promoting strong accountability and transparency in health systems.Conclusions Results from this study highlight the strengths, weaknesses and recent trajectories of anti-corruption in the Global Fund, World Bank, UNDP and WHO. This study underscores the importance of implementing strong and robust anti-corruption mechanisms specifically geared towards corruption prevention that remain resilient even in times of emergency. |
| format | Article |
| id | doaj-art-0fe89871e45b4558af9cce29ea819ebe |
| institution | OA Journals |
| issn | 2044-6055 |
| language | English |
| publishDate | 2022-12-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-0fe89871e45b4558af9cce29ea819ebe2025-08-20T02:15:58ZengBMJ Publishing GroupBMJ Open2044-60552022-12-01121210.1136/bmjopen-2022-064137Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisationsJillian Kohler0Ariel Gorodensky1Andrea Bowra2Gul Saeed3University of Toronto Leslie Dan Faculty of Pharmacy, Toronto, Ontario, CanadaUniversity of Toronto Leslie Dan Faculty of Pharmacy, Toronto, Ontario, CanadaUniversity of Toronto Dalla Lana School of Public Health, Toronto, Ontario, CanadaWHO Collaborating Centre for Governance, Accountability, and Transparency in the Pharmaceutical Sector, Toronto, Ontario, CanadaObjectives Corruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors globally. Throughout the COVID-19 pandemic, weakened health systems and overlooked regulatory processes have increased corruption risks. The objective of this study is thus to explore the strengths and weaknesses of these organisations’ anti-corruption mechanisms and their trajectories since the pandemic began.Design, setting and participants 25 semistructured key informant interviews with a total of 27 participants were conducted via Zoom between April and July 2021 with informants from WHO, World Bank, Global Fund and UNDP, other non-governmental organisations involved in anti-corruption and academic institutions. Key informant selection was guided by purposive and snowball sampling. Detailed interview notes were qualitatively coded by three researchers. Data analysis followed an inductive-deductive hybrid thematic analysis framework.Results The findings demonstrate that WHO, World Bank, Global Fund and UNDP have shifted from criminalisation/punitive approaches to anti-corruption to preventative ones and that anti-corruption initiatives are strong when they are well funded, explicitly address corruption and are complemented by strong monitoring and evaluation mechanisms. Weaknesses in the organisations’ approaches to anti-corruption include one-size-fits-all approaches, lack of political will to address corruption and zero-tolerance policies for corruption. The COVID-19 pandemic has highlighted the necessity of improving anti-corruption by promoting strong accountability and transparency in health systems.Conclusions Results from this study highlight the strengths, weaknesses and recent trajectories of anti-corruption in the Global Fund, World Bank, UNDP and WHO. This study underscores the importance of implementing strong and robust anti-corruption mechanisms specifically geared towards corruption prevention that remain resilient even in times of emergency.https://bmjopen.bmj.com/content/12/12/e064137.full |
| spellingShingle | Jillian Kohler Ariel Gorodensky Andrea Bowra Gul Saeed Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations BMJ Open |
| title | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
| title_full | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
| title_fullStr | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
| title_full_unstemmed | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
| title_short | Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations |
| title_sort | anti corruption in global health systems using key informant interviews to explore anti corruption accountability and transparency in international health organisations |
| url | https://bmjopen.bmj.com/content/12/12/e064137.full |
| work_keys_str_mv | AT jilliankohler anticorruptioninglobalhealthsystemsusingkeyinformantinterviewstoexploreanticorruptionaccountabilityandtransparencyininternationalhealthorganisations AT arielgorodensky anticorruptioninglobalhealthsystemsusingkeyinformantinterviewstoexploreanticorruptionaccountabilityandtransparencyininternationalhealthorganisations AT andreabowra anticorruptioninglobalhealthsystemsusingkeyinformantinterviewstoexploreanticorruptionaccountabilityandtransparencyininternationalhealthorganisations AT gulsaeed anticorruptioninglobalhealthsystemsusingkeyinformantinterviewstoexploreanticorruptionaccountabilityandtransparencyininternationalhealthorganisations |